CD44 and cancer: Moreover, the popliteal lymph node of tumor-bearing mouse at 1 h after intra-footpad injection of DXBTZ-CB[8]/CSA displays in greenish blue color, suggesting that the nanoagent can track the metastatic cancer cells in lymphatic system via CD44 targeting.